In 40 seconds
Chronic low-grade inflammation underlies osteoarthritis, autoimmune conditions, cardiovascular disease, depression, dementia, and many chronic pain syndromes. PEMF therapy reduces inflammation through multiple validated mechanisms: lowering pro-inflammatory cytokines (IL-1β, TNF-α, IL-6), increasing nitric oxide release (vasodilation, anti-inflammatory effect), supporting parasympathetic activation, and improving microcirculation to clear inflammatory metabolites. This is why PEMF helps so many conditions that share inflammation as a root mechanism — joint pain, recovery, autoimmune support, and more.
Quick facts
- Inflammatory markers reduced: IL-1β, TNF-α, IL-6, MMPs
- Nitric oxide: Increased — vasodilatory, anti-inflammatory
- Vagal / parasympathetic: Activated
- Microcirculation: Improved
- Why it helps: Many conditions share inflammation as root cause
Practical guidance
See FAQ below for specific scenarios.
Contraindications
Standard PEMF contraindications: pacemakers, defibrillators, cochlear implants, insulin pumps, electronic implants; active malignancy without specialist clearance; pregnancy (over the abdomen); active infection; epilepsy without GP clearance.
Frequently asked questions
Does PEMF really reduce inflammation?
Yes — measurably. Multiple studies show reduced inflammatory cytokines and improved markers in tissue and blood after PEMF therapy.
Is it as good as anti-inflammatory medication?
Different mechanism, no medication side effects. Many patients reduce NSAID use under medical guidance after starting PEMF.
What about systemic inflammation?
Full-body mat PEMF protocols are designed to influence systemic inflammation. Localised applicators target specific tissues.
Will it help my autoimmune condition?
Possibly — by reducing inflammatory burden. Always alongside specialist care, never instead of disease-modifying treatment.
Looking for a PEMF clinic near you?
We list every credible PEMF therapy provider in the UK so you can find one near home.